- The Tiger's Prey
- Posts
- CuriosityStream Inc.
CuriosityStream Inc.
NasdaqCM:CURI
Hello. A few weeks ago, I published a surface-level review of CURI, ranking it as “Highest Priority” while placing it behind a paywall and redacting the name for free subscribers. It was clear from the start that unless a major red flag emerged during the deep dive process, this would be the focus of my next write-up.
Fast forward to today, CURI is already up ~30%, having increased its dividend by 20%. Yet, it remains a classic low risk, high uncertainty opportunity, offering strong downside protection and unlimited potential for upside surprises. There’s no time to waste, so let’s dive in.
IMPORTANT NOTE: To the best of my knowledge, CURI is now under increasing scrutiny, with more institutional eyeballs closely watching.
Thanks for reading, and I hope you find this valuable.
PREVIEW
FIRST PAGE

If you have any questions or feedback, don't hesitate to reach out via email at [email protected].
Until next time,
The Tiger’s Prey